https://gebro.es/ene-2024-sergi-aulinas-gebro-pharma-hay-que-actuar-en-el-precio-de-los-farmacos-regulados-esenciales-para-que-sean-rentables/2024-06-21T09:29:01+00:00https://gebro.es/bit-pharmas-nicaplant-implants-licensed-in-spain-by-laboratorios-gebro-pharma-achieve-the-emas-prime-designation/2024-06-21T09:28:38+00:00https://gebro.es/gebro-pharma-y-adalvo-lanzan-dalingo-pregabalina-de-liberacion-retardada-un-farmaco-destinado-a-los-pacientes-adultos-con-dolor-neuropatico/2024-06-21T09:29:28+00:00https://gebro.es/gebro-pharma-afianza-su-area-de-respiratorio-con-el-lanzamiento-de-zandraqet-citisiniclina-un-farmaco-destinado-a-la-deshabituacion-tabaquica-y-nicotinica/2025-12-03T11:40:07+00:00https://gebro.es/sandra-la-solucion-de-inteligencia-artificial-de-gebro-pharma-que-acompana-a-los-pacientes-a-dejar-de-fumar/2025-12-03T10:34:12+00:00https://gebro.es/gebro-pharma-y-the-ricky-rubio-foundationunen-fuerzas-en-una-campana-conjunta-contra-el-tabaquismo/2025-05-30T09:28:43+00:00https://gebro.es/gebro-pharma-afianza-su-area-de-reumatologia-con-el-lanzamiento-de-izamby-un-farmaco-antirresortivo-destinado-al-tratamiento-de-la-osteoporosis-en-pacientes-adultos/2026-03-30T14:25:00+00:00